Oregon Public Employees Retirement Fund’s Ligand Pharmaceuticals LGND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$505K Buy
4,442
+100
+2% +$11.4K 0.01% 1111
2025
Q1
$457K Sell
4,342
-100
-2% -$10.5K 0.01% 1143
2024
Q4
$476K Buy
4,442
+132
+3% +$14.1K 0.01% 1177
2024
Q3
$431K Buy
4,310
+200
+5% +$20K 0.01% 1205
2024
Q2
$346K Sell
4,110
-300
-7% -$25.3K 0.01% 1250
2024
Q1
$322K Sell
4,410
-388
-8% -$28.4K 0.01% 1301
2023
Q4
$343K Sell
4,798
-30
-0.6% -$2.14K 0.01% 1335
2023
Q3
$289K Sell
4,828
-300
-6% -$18K ﹤0.01% 1472
2023
Q2
$370K Hold
5,128
﹤0.01% 1418
2023
Q1
$377K Sell
5,128
-210
-4% -$15.4K ﹤0.01% 1400
2022
Q4
$357K Sell
5,338
-3,200
-37% -$214K ﹤0.01% 1428
2022
Q3
$459K Sell
8,538
-335
-4% -$18K 0.01% 1295
2022
Q2
$494K Sell
8,873
-1,165
-12% -$64.9K 0.01% 1129
2022
Q1
$704K Sell
10,038
-321
-3% -$22.5K 0.01% 1256
2021
Q4
$998K Sell
10,359
-480
-4% -$46.2K 0.01% 1011
2021
Q3
$942K Buy
10,839
+1,760
+19% +$153K 0.01% 1031
2021
Q2
$743K Buy
9,079
+500
+6% +$40.9K 0.01% 1173
2021
Q1
$816K Hold
8,579
0.01% 1113
2020
Q4
$532K Sell
8,579
-404
-4% -$25.1K 0.01% 1215
2020
Q3
$534K Sell
8,983
-829
-8% -$49.3K 0.01% 1085
2020
Q2
$685K Sell
9,812
-733
-7% -$51.2K 0.01% 969
2020
Q1
$478K Sell
10,545
-2,133
-17% -$96.7K 0.01% 1044
2019
Q4
$825K Sell
12,678
-1,388
-10% -$90.3K 0.01% 989
2019
Q3
$873K Buy
14,066
+248
+2% +$15.4K 0.01% 1018
2019
Q2
$984K Buy
13,818
+188
+1% +$13.4K 0.01% 971
2019
Q1
$1.07M Buy
13,630
+147
+1% +$11.5K 0.02% 910
2018
Q4
$1.14M Buy
+13,483
New +$1.14M 0.02% 826